2020 FDA Approvals: A Year in Review by Lara Frick March 15, 2021CDER, Center for Drug Evaluation and Research, FDA, FDA Approvals, Food and Drug Administration, Magellan Health, Magellan RX, Magellan Rx Management, New Drugs, Novel agents, Novel drugs, Orphan Drugs
Alternative Cost-Saving Strategies for Innovative Treatments: Will Medicaid Enter the Value-Based Pricing Market? by Lara Frick September 23, 2020Magellan Health, Magellan RX, Magellan Rx Management, Medicaid, Novel Medications, Outcome Based Pricing, Specialty Pharmacy Trend Alert, Trend Alert, Value Based Purchasing
Traditional Drug to Biologic: A Change 10 Years in the Making by Lara Frick June 22, 2020Biologics, Biosimilars, Drug Approvals, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Traditional Drugs
2019 FDA Approvals: A Year in Review by Lara Frick March 19, 2020Biosimilairs, FDA, FDA Approvals, Magellan Health, Magellan RX, Magellan Rx Management, New Drugs, Novel drugs, Orphan Drugs, Trend Alert
Drone-to-Door – The Ascent of The Airborne Pharmacy by Maryam Tabatabai January 27, 2020airborne pharmacy, Drone Delivery, Drone-to-door, on-demand healthcare, prescription delivery
“Drug Shortages: Root Causes and Potential Solutions” – Insight from a FDA Task Force by Lara Frick December 4, 2019Drug Shortages, FDA Drug Shortages, FDA Task Force, Magellan Health, Magellan RX, MEDS Act, MRx, MRx Trend Alert, Trend Alert
Mental Health in America – Perception and Reality 30 Years Later by Lara Frick October 9, 2019Depression, Healthcare, Magellan, Magellan Health, Magellan Healthcare, Mental Health, Mental Illness, Suicide, Suicide Prevention
21st Century Measles Outbreak by Maryam Tabatabai July 25, 2019CDC, Immunization, Magellan Pharmacy, Magellan Pharmacy Benefits, Measles, Measles Virus, Trend Alert, Vaccination
